A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.

A participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous ...

It was given to people who had acute surgical pain from either abdominoplasty, also known as a tummy tuck, or bunion surgery.

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...